A phase II trial of thalidomide and capecitabine in metastatic renal cell carcinoma.
Phase of Trial: Phase II
Latest Information Update: 18 May 2010
At a glance
- Drugs Capecitabine; Thalidomide
- Indications Renal cancer
- Focus Therapeutic Use
- 12 May 2009 Additional lead trial investigator (Srinivas S) identified as reported by ClinicalTrials.gov.
- 14 Jun 2007 Status changed from in progress to completed
- 27 Nov 2005 New trial record.